User profiles for M. Pierantozzi
Mariano PierantozziUniversitą di Chieti Pescara Verified email at unich.it Cited by 1085 |
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease
…, P Stanzione, S Galati, D Tropepi, M Pierantozzi… - Brain, 2007 - academic.oup.com
Gait disturbances and akinesia are extremely disabling in advanced Parkinson's disease. It
has been suggested that modulation of the activity of the pedunculopontine nucleus (PPN) …
has been suggested that modulation of the activity of the pedunculopontine nucleus (PPN) …
Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains
…, R Ceravolo, L Brusa, M Pierantozzi… - Journal of the …, 2010 - Elsevier
Between 2005 and 2007, six patients affected by idiopathic Parkinson's disease (IPD) were
submitted to the bilateral implantation (and subsequent deep brain stimulation — DBS) of the …
submitted to the bilateral implantation (and subsequent deep brain stimulation — DBS) of the …
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Objective Coronavirus disease 2019 (COVID-19) represents a novel pneumonia leading to
severe acute respiratory syndrome (SARS). Recent studies documented that SARS-…
severe acute respiratory syndrome (SARS). Recent studies documented that SARS-…
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
…, O Rascol, JF Demonet, A Stefani, M Pierantozzi… - Brain, 2010 - academic.oup.com
One objective of modern neuroimaging is to identify markers that can aid in diagnosis,
disease progression monitoring and long-term drug impact analysis. In this study, Parkinson-…
disease progression monitoring and long-term drug impact analysis. In this study, Parkinson-…
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
M Pierantozzi, A Pietroiusti, L Brusa, S Galati… - Neurology, 2006 - AAN Enterprises
Objective: To investigate if Helicobacter pylori (HP) eradication could make an effective and
long-lasting improvement in the pharmacokinetic and clinical response to l-dopa in patients …
long-lasting improvement in the pharmacokinetic and clinical response to l-dopa in patients …
[HTML][HTML] COVID 19—A qualitative review for the reorganization of human living environments
… This greatly complicates the simple reduction to two types of distances of 2 or 6 m but also
… The only exception was a crowd collection site about 1 m from the entrance of a department …
… The only exception was a crowd collection site about 1 m from the entrance of a department …
Dysbiosis of gut microbiota in a selected population of Parkinson's patients
…, R Cerroni, V Unida, A Farcomeni, M Pierantozzi… - Parkinsonism & related …, 2019 - Elsevier
Introduction In recent years the hypothesis that gut microbiota associates with Parkinson's
disease (PD) has gained importance, although it has not been possible to define a specific …
disease (PD) has gained importance, although it has not been possible to define a specific …
[HTML][HTML] Neurotrophins as therapeutic agents for Parkinson's disease; new chances from focused ultrasound?
A Stefani, M Pierantozzi, S Cardarelli… - Frontiers in …, 2022 - frontiersin.org
Magnetic Resonance–guided Focused Ultrasound (MRgFUS) represents an effective micro-lesioning
approach to target pharmaco-resistant tremor, mostly in patients afflicted by …
approach to target pharmaco-resistant tremor, mostly in patients afflicted by …
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease
…, MG Marciani, M Pierantozzi - Journal of Neurology …, 2015 - jnnp.bmj.com
Objectives To investigate, in patients with Alzheimer's Disease (AD), the possible interplay
linking alteration of neuronal energy metabolism, as measured via cerebrospinal fluid (CSF) …
linking alteration of neuronal energy metabolism, as measured via cerebrospinal fluid (CSF) …
[HTML][HTML] Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease
V Pisani, A Stefani, M Pierantozzi, S Natoli… - Journal of …, 2012 - Springer
Background Alterations in blood–brain barrier permeability have been proposed to represent
a relevant factor contributing to Parkinson’s disease progression. However, few studies …
a relevant factor contributing to Parkinson’s disease progression. However, few studies …